Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Blair James C
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   127,185    

Indirect Shares

  2,985,991      
Direct Value   $138,020    

Indirect Value

  $9,762,965      
Total Shares   3,113,176      
Total Value   $9,900,985      


Nuvasive Inc
 $137,416 Volcano Corp
 $0 Orexigen Therapeutics, Inc.
 $103 Clovis Oncology, Inc.
 $502 Nuvasive Inc
 $137,416 Volcano Corp
 $0 Orexigen Therapeutics, Inc.
 $103 Clovis Oncology, Inc.
 $502
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Welltek Incorporated WTKND Director 2008-03-07 0 2008-03-07 0    Premium*  
            Nuvasive Inc NUVA Director 2007-05-09 3,457 2007-05-09 0    Premium*  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 0 2006-12-21 19,379    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 0 2006-05-10 37,586    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-15 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 70,916 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX Director, 10% Owner 0 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 19,373 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2010-04-27 0 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX Director, 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS Director 2019-08-16 33,439 2019-08-20 30,105    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT 10% Owner 2013-11-04 0 2013-11-04 22,730    Premium*  
            Tandem Diabetes Care Inc TNDM 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
* Premium Members only  

Records found :    183         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
AKAO Achaogen Inc 10% Owner   –       –       •   2014-03-17 4 A $0.00 $0 I/I 2,020,939 33,890 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2010-08-20 3 IO $0.00 $0 I/I 0 8,032,129 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2010-10-06 4 A $0.00 $0 I/I 25,000 25,000 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2012-05-31 4 A $0.00 $0 I/I 93,434 93,434 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2012-05-31 4 D $0.00 $0 I/I (1,200,000) 6,772,968 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-01-18 4 A $0.00 $0 I/I 66,462 159,896 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-01-18 4 D $0.00 $0 I/I (1,000,000) 5,772,968 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2010-04-27 4 B $11.00 $4,158,308 I/I 378,028 4,829,773 1.5 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2010-04-27 4 A $0.00 $0 I/I 4,499,449 47,704 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2011-06-02 4 S $8.04 $55,589 I/I (6,914) 40,790 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2011-06-02 4 A $0.00 $0 I/I 18,864 18,864 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2011-06-02 4 D $0.00 $0 I/I (700,000) 4,129,773 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2006-10-24 3 IO $0.00 $0 I/I 0 27,500 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2006-10-30 4 A $0.00 $0 I/I 5,713,622 60,584 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2008-02-20 4 A $5.34 $14,999,996 I/I 2,808,988 90,369 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2009-02-18 4 B $7.13 $19,826,206 I/I 2,780,674 46,634 2.25 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2014-03-19 4 D $14.00 $146,195,434 I/I (10,442,531) 0 0 -
CLVS Clovis Oncology, Inc. Director   –       •       •   2011-11-21 4 A $0.00 $0 I/I 2,110,267 35,388 0 -
CLVS Clovis Oncology, Inc. Director   –       •       •   2011-11-21 4 B $13.00 $12,111,879 I/I 931,683 51,013 2.25 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2015-03-03 4 D $0.00 $0 I/I (500,000) 2,081,745 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2015-03-05 4 S $77.70 $662,626 I/I (8,528) 35,506 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2015-07-16 4/A A $0.00 $0 I/I 2,927 2,927 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2015-07-16 4 A $0.00 $0 D/D 2,185 2,185 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2015-07-16 4 D $0.00 $0 I/I (41,813) 0 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2015-09-22 4 D $0.00 $0 I/I (794,888) 1,286,857 0 -

  183  Records found
  1  2   3   4   5   6   7   8      
  Page 1 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed